Loading...
Not a good buy right now. PFSI is experiencing a severe post-earnings repricing (about -26% pre-market) on an earnings/revenue miss, with hedge funds actively selling and no proprietary buy signals. For an impatient investor unwilling to wait for stabilization, the risk/reward is unfavorable today; the better call is to stay on the sidelines until price action bases and volatility compresses.
Pre-market is indicating a major gap-down to 110.21 from the prior reference area (149.7 in the options snapshot), which likely breaks the prior support zone (S1 ~147.09, S2 ~143.70) and invalidates the prior bullish moving-average stack (SMA_5 > SMA_20 > SMA_200) for near-term trading.
Intellectia Proprietary Trading Signals

Latest quarter: 2025/Q4.
Recent trend: price targets were raised into late 2025/early 2026 (BTIG to $150 on 2025-12-29; Barclays to $158 on 2026-01-06), then turned more cautious after the Q4 report (Barclays cut to $136 on 2026-01-30, citing “cracks”). BTIG maintained Buy/$150 and framed the drop as a “buy on weakness,” while Barclays kept Overweight but reduced estimates. Wall Street pros: inexpensive valuation framing (~10x earnings per BTIG), leverage to improved mortgage origination/refi conditions and possible housing-policy support. Wall Street cons: earnings sensitivity to prepayment speeds/hedging dynamics, competitive pressure, and now reduced confidence after the miss and Barclays’ model-concern language. Influential/political trading: No recent congress trading data available; insiders are neutral with no significant recent trend.